NCT01989416

Brief Summary

The purpose of this study is to determine 2% chlorhexidine wipes are effective in preventing of colonization of multi-drug resistant bacteria in intensive care unit patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
481

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Dec 2013

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 21, 2013

Completed
10 days until next milestone

Study Start

First participant enrolled

December 1, 2013

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

December 2, 2015

Status Verified

November 1, 2015

Enrollment Period

1.1 years

First QC Date

October 13, 2013

Last Update Submit

November 30, 2015

Conditions

Keywords

colonization

Outcome Measures

Primary Outcomes (1)

  • The overall rate of Multidrug resistant bacteria acquisition at 7 days after received 2% chlorhexidine wipe bathing versus with soap bathing

    7 days after received 2% chlorhexidine wipes,the microbiology laboratory will process surveillance specimens using either standard culture-based at both nostrils, axillar, groins, rectum

    7 days after recieved 2% chlorhexidine wipes

Secondary Outcomes (1)

  • The overall rate of hospital-acquired bloodstream infections per 1000 patient-days with chlorhexidine wipe bathing versus with soap bathing

    48 hours after recieved 2% chlorhexidine wipes

Study Arms (2)

Soap bathing

PLACEBO COMPARATOR

ICU patients will be bathing with soap at least once daily

Drug: Soap

2% chlorhexidine wipes

EXPERIMENTAL

Use 2% chlorhexidine wipes to clean the patient at least once daily

Drug: 2% chlorhexidine wipe

Interventions

The ICU patients will be bathing with 2% chlorhexidine wipe

Also known as: chlorhexidine wipe
2% chlorhexidine wipes
SoapDRUG

The ICU patients will be bathing with Soap

Also known as: Control soap
Soap bathing

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • Admission in critical care unit eg. ICU, respiratory care unit, Cardiac care unit with in 24 hours
  • Expected duration of critical care unit admission \> 48 hours

You may not qualify if:

  • History of chlorhexidine allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok, Bangkok, 10700, Thailand

Location

Related Publications (1)

  • Boonyasiri A, Thaisiam P, Permpikul C, Judaeng T, Suiwongsa B, Apiradeewajeset N, Fakthongphan T, Suddee S, Laoagtipparos W, Thamlikitkul V. Effectiveness of Chlorhexidine Wipes for the Prevention of Multidrug-Resistant Bacterial Colonization and Hospital-Acquired Infections in Intensive Care Unit Patients: A Randomized Trial in Thailand. Infect Control Hosp Epidemiol. 2016 Mar;37(3):245-53. doi: 10.1017/ice.2015.285.

MeSH Terms

Interventions

Soaps

Intervention Hierarchy (Ancestors)

DetergentsSurface-Active AgentsSpecialty Uses of ChemicalsChemical Actions and UsesHousehold ProductsTechnology, Industry, and Agriculture

Study Officials

  • Adhiratha Boonyasiri, MD

    Mahidol University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

October 13, 2013

First Posted

November 21, 2013

Study Start

December 1, 2013

Primary Completion

January 1, 2015

Study Completion

April 1, 2015

Last Updated

December 2, 2015

Record last verified: 2015-11

Locations